Calypte Biomedical Corp (fka CBMC)

[cal_pn]

coinstarz - expedited review

I was a bit surprised that expedited review was discussed earlier by the company in CCs but actually not touched in the PR.

Typically a company won't be shy of announcing expedited review when it is granted (it is a positive). One could even speculate that it would be good practise to announce it because it is a material event (just my opinion) and will affect investors' decisions.

So one conclusion could be that Calypte has not received priority review (or not yet, I don't know).

However, the company also took its time to announce the filing to the sFDA recently. I think they announced it almost two weeks after it actually occurred. So I would not be surprised if they have indeed expedited review (or some status effectively equivalent) but have not told us yet. One possible reason for not mentioning it, is the realistic expectation that approval will be received soon.

It seems that the company is now very cautious when announcing info publically, which is a change to earlier times. Possibly this is due to the confusion that built up after Roger Gale indicated twice a CC without doing it afterwards. People might have phoned the company for weeks and complained about it.

This leads also to the question whether there is significant progress on other fields which has not been made public yet. We don't know.

Cal